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Background: Sox 9 is a major marker of chondrocyte differentiation. When chondrocytes are cultured in vitro they
progressively de-differentiate and this is associated with a decline in Sox 9 expression. The active form of vitamin D,
1, 25 (OH)2D3 has been shown to be protective of cartilage in both humans and animals. In this study equine
articular chondrocytes were grown in culture and the effects of 1, 25 (OH)2D3 upon Sox 9 expression examined. The
expression of the transient receptor potential vanilloid (TRPV) ion channels 5 and 6 in equine chondrocytes in vitro,
we have previously shown, is inversely correlated with de-differentiation. The expression of these channels in
response to 1, 25 (OH)2D3 administration was therefore also examined.
Results: The active form of vitamin D (1, 25 (OH)2D3) when administered to cultured equine chondrocytes at two
different concentrations significantly increased the expression of Sox 9 at both. In contrast 1, 25 (OH)2D3 had no
significant effect upon the expression of either TRPV 5 or 6 at either the protein or the mRNA level.
Conclusions: The increased expression of Sox 9, in equine articular chondrocytes in vitro, in response to the active
form of vitamin D suggests that this compound could be utilized to inhibit the progressive de-differentiation that is
normally observed in these cells. It is also supportive of previous studies indicating that 1α, 25-dihydroxyvitamin D3
can have a protective effect upon cartilage in animals in vivo. The previously observed correlation between the
degree of differentiation and the expression levels of TRPV 5/6 had suggested that these ion channels may have a
direct involvement in, or be modulated by, the differentiation process in vitro. The data in the present study do not
support this.
Keywords: Cartilage, Vitamin D, Sox 9, TRPV, ChondrocyteBackground
The active metabolite of vitamin D, 1, 25 (OH)2D3 has
been reported to be involved in the regulation of cellular
functions such as differentiation, proliferation, and the im-
mune system [1]. Similar to other steroids, 1, 25 (OH)2D3
exerts physiological actions at two levels by genomic
and non-genomic mechanisms. The genomic mechanism* Correspondence: paul.loughna@nottingham.ac.uk
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article, unless otherwise stated.exerts its effect on the cells by binding to specific recep-
tors known as vitamin D receptors, which in turn bind to
retinoid X receptors to form heterodimeric complexes [2].
These heterodimeric complexes in turn bind to VDREs
(vitamin D responsive elements) of the upstream region of
the responsive gene leading to activation/suppression of
the target gene. In contrast, the non-genomic effect of 1,
25 (OH)2D3 is mediated though plasma membrane recep-
tors of the target cells which are involved in ion channel
activity regulation and also activate signal transduction
pathways [3,4]. Exogenous 1, 25 (OH)2D3 in mice in-
creased chondrocyte proliferation as well as enhancingntral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Hdud and Loughna Journal of Animal Science and Technology 2014, 56:33 Page 2 of 8
http://www.janimscitechnol.com/content/56/1/33cartilage matrix mineralization [5]. The profound effects
of vitamin D on calcium metabolism are well established
and it has been reported that it can protect against cartil-
age loss in osteoarthritis in humans and rats [6].
Sox 9 (Sry-type high mobility group domain) transcrip-
tion factor is expressed in articular chondrocytes, central
nervous and urogenital systems [7,8]. It is expressed in all
primordial cartilage tissues during embryogenesis [8,9]
and functions to induce differentiation of stem cells to
chondrocytes [10], regulate cartilage development and
phenotypic maintenance during embryonic development
[11]. Studies indicate that Sox 9 is involved in chondrocyte
differentiation by regulating the expression of cartilage-
specific genes such as collagen type IIα1 [8,12], XIα2 [13],
aggrecan [14], collagen link protein [15], cartilage oligo-
meric matrix protein and Cd-rap [16]. It has been shown
that Sox 9 expression is maintained in articular chondro-
cytes and reduced in osteoarthritic chondrocytes [17].
Haploinsufficiency of Sox 9 results in campomelic dys-
plasia, a severe syndrome resulting in inadequate car-
tilage formation during development leading to severe
dwarfism [18]. In chimaeric mice, Sox 9−/− the prechon-
drogenic mesenchyme cells were prevented from differ-
entiating into chondrocytes and lost their ability to
express chondrocyte specific genes [19,20]. Sox 9 expres-
sion is also significantly reduced in osteoarthritic cartil-
age compared to normal healthy cartilage [17,21].
In vitro propagation of articular chondrocytes results
in de-differentiation that is characterized by gradual loss
of chondrocytic phenotype and acquisition of a fibroblas-
tic phenotype [22] which is associated with a rapid decline
in Sox 9 expression [23]. We have previously shown in
equine chondrocytes that there is an association between
the degree of de-differentiation and the expression and
the transient receptor potential vanilloid (TRPV) channels
5 and 6 [24].
The transient receptor potential (TRP) superfamily is a
non-selective cation ion channels with relative calcium
selectivity. The TRPV sub-family is divided into two groups.
TRPV1-4 channels are non-selective ion channels with
modest permeation to calcium. This group can be acti-
vated by different stimuli such as heat/cold, chemical/
mechanical stresses and binding to second messengers
[25,26]. The other group comprises of TRPV5 and TRPV6
channels that are highly calcium selective and tightly regu-
lated by cytosolic Ca2+ concentration [27,28]. The TRPV5
channel is implicated in Ca2+ reabsorption from the kid-
ney, whereas TRPV6 channel is involved in Ca2+ absorp-
tion in the intestine [29]. Expression of both channels in
human articular chondrocytes at mRNA level has been re-
ported [30]. We also demonstrated their expression at the
protein levels in equine articular chondrocytes (EAC) [24].
A correlation between the expression of TRPV5/6 chan-
nels and administered 1, 25 (OH)2D3 concentration hasalso reported in intestinal endothelial cells [31,32], renal
cells [33], osteoblasts [34,35]. Calbindin-D9K is a cytosolic
Ca2+ binding protein, a member of cellular proteins found
in the cells with high affinity for Ca2+ ions. Calbindin-D9k
knockout mice models demonstrated that 1, 25 (OH)2D3
intake increased the expression of both channels [36]. The
aim of the present study was to examine the effects of 1,
25 (OH)2D3 on the expression of Sox 9 and TRPV 5 and 6
in cultured equine chondrocytes.Methods
Chondrocyte isolation
Articular chondrocytes were isolated from equine articu-
lar cartilage removed from load bearing synovial joints
(metacarpophalangeal joints) of skeletally mature ani-
mals obtained on the day of slaughter from a local abat-
toir; these animals were euthanized for purposes other
than research. All experiments were performed with local
institutional ethical approval (University of Nottingham,
School of Veterinary Medicine and Science Ethical Com-
mittee), in strict accordance with national guidelines. Arti-
cular cartilage slices were collected in serum free DMEM
medium supplemented with 2% antibiotics (50 U/ml peni-
cillin and 50 μg/ml streptomycin) (Invitrogen, UK). Carti-
lage slices were washed in phosphate buffer saline (PBS)
supplemented with 10% antibiotics (50 U/ml penicillin
and 50 μg/ml) for 30 min with agitation, followed by
enzymatic digestion in freshly prepared 0.1% (v/w) col-
lagenase type I from clostridium histolyticum enzyme
dissolved in serum free medium supplemented with 2%
antibiotics at relative humidity of 95%, 5% CO2, 37?C for
18 h. Undigested cartilage debris were removed from the
cell/medium suspension by filtering the mixture through a
nylon filter strainer of 70 μm pore size (BD Bioscience,
Europe). Supernatant was spun to isolate the chondro-
cytes, followed by three washes using PBS containing 10%
antibiotics. Finally cells were suspended in DMEM con-
tains 2% antibiotics and 10% FCS and cultured at 37?C,
95% humidity and 5% CO2 until confluent. Cells viabil-
ity was assessed by the trypan blue exclusion test (Sigma
Aldrich, UK).Vitamin D treatment
To explore the influence of the active form of vitamin D
(1, 25, α-dihydroxy vit D) on equine articular chondro-
cytes, cells were cultivated at 2 ? 10 5 cells/well until
sub-confluence. Chondrocytes were treated with different
concentrations of 1, 25 (OH)2D3 (1 ? 10
−9 and 1 ? 10 −12)
[37] in serum free-medium for 24 h. The concentration of
DMSO was below 0.1%. At the end of 1, 25 (OH)2D3
treatment, cells were washed three times sterile PBS and
whole cell lysate was collected for protein expression
using western blotting.
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Total cellular protein lysate was isolated using radio-
immunopreceptation assay (RIPA) buffer (150 mM NaCl,
50 mM Tris? HCl, pH 7.5, 5 mM ethylene glycol tetraace-
tic acid (EGTA), 1% Triton, 0.5% sodium deoxycholate
and 0.1% sodium dodecyl sulphate) supplemented with
phosphatase and protease inhibitors cocktail (Roche Diag-
nostic, Mannheim, Germany) on ice. Protein concentra-
tion was quantified by the Bradford method. 25 μg of total
protein lysate was mixed with sample buffer (0.5 M Tris?
HCl, pH 6.8, 100% glycerol, 20% SDS, 0.5% bromo-
phenol blue and 5% β-mercaptoethanol), separated on
a 4/1-% polyacrylamide gel, then electrically transferred
to PVDF membrane (Invitrogen, UK) by semi-dry appa-
ratus (Bio-Rad, UK). Transferred proteins were blocked
for non-specific binding in 5% (w/v) non-fat milk diluted
in Tris base buffer saline with 0.1% tween 20 (TBS-T),
followed by incubation with designated antibodies over-
night. Membranes were washed five times in TBST,
followed by 1 h incubation with goat anti-rabbit IgG
conjugated with horseradish peroxidase (HRP) (Dako,
UK) secondary antibody at room temperature. Finally, five
washes were carried out for 5 min each followed by devel-
oping the membrane with the Amersham ECL western
blot enhanced chemiluminescence kit (GE Healthcare,
UK) and visualized by exposing to X-ray film.
Quantitative PCR
The quantitative real time PCR was carried out using a
LightCycler? 480 PCR System (Roche Diagnostics) using
SYBR green DNA-binding fluorescent dye. 20 μl reactions
were made in an optical 96-well reaction plate in triplicate
and contained: a mixture of template cDNA (5 μl), sense
and anti-sense gene specific primers (0.8 μl) (20 pmol),
SYBR Green detection reagent and 3.4 μl RNA-free water.
Reaction plate was sealed with ABI-prism optical adhe-
sive cover, and spun at 2000 rpm for 2 min. The expres-
sion of target genes were normalised against GAPDH
(Glyceraldehyde 3-phosphate dehydrogenase) and HPRT
(Hypoxanthine-guanine phosphoribosyltransferase) using
comparative cycle of threshold (Ct) value method.
Statistical analysis
Data values are presented as the mean ? SEM. Each ex-
periment was performed in triplicate. The relative expres-
sion on the graphs represents the mean of a combination
of three experiments. The differences between animals
were analyzed utilizing Student? s t-test followed by the
Bonferroni correction. P values less than or equal to 0.05
were considered statically significant.
Results and discussion
The active form of vitamin D (1, 25 (OH)2D3) has been
shown to play an important role in Ca2+ homeostasis.Intracellular Ca2+ concentration is involved in several
chondrocyte functions including ECM biosynthesis.
This study was designed to explore the possible influ-
ence of the active form of vitamin D (1, 25 (OH)2D3)
treatment on the expression of Sox 9 and members of
the TRP subfamily that are known as epithelial Ca2+
channels (TRPV5 and TRPV6 channels).
The influence of two doses (1 ? 10 −9 and 1 ? 10 −12) of
1, 25 (OH)2D3 treatment for 24 h on the expression of
the transcription factor (Sox 9) at the protein level in
equine chondrocytes was examined. Incubation of chon-
drocytes for 24 h with 1 ? 10 −12 of 1, 25 (OH)2D3 sig-
nificantly increased the expression of Sox 9 by nearly 3
fold, whereas treatment with 1 ? 10 −9 of 1, 25 (OH)2D3
induced more than 2 fold increase (P < 0.001) compared
to the non-treated cells (Figure 1).
In chondrocytes, the mechanisms by which Sox 9 ex-
pression is regulated is of great interest due to the crit-
ical role played by this transcription factor in controlling
the chondrocyte phenotype. The findings of the present
study shows an elevation of Sox 9 protein in response to
treatment with 1, 25 (OH)2D3. Isolation of chondrocytes
results in their de-differentiation and loss of chondrocyte
phenotype to fibroblast phenotype [22]. Recent studies
have reported changes in the pattern of expression of
some proteins during the course of chondrocytes de-
differentiation. Cultivation of de-differentiated chondro-
cytes in alginate gel results in restoring the expression of
transcription factor Sox 9 and chondrocyte differentiation
markers such as collagen type II and aggrecan [38]. The
current study indicated that treatment of cultured chon-
drocytes with 1, 25 (OH)2D3 results in restoring of the
transcription factor Sox 9, which could indicate chondro-
cyte re-differentiation and restoration of the chondrocyte
phenotype.
The physiological activities of Sox 9 protein were
demonstrated by mouse genetic studies which indicated
the importance of Sox 9 expression level in determining
chondrocyte phenotype during development [39,40].
These studies demonstrated that chondrocyte differen-
tiation and cartilage development were severely affected
by knock-out or knock-in of a single allele of Sox 9.
Moreover, the campomelic dysplasia is a genetic disorder
characterized by multiple developmental abnormalities
including cartilage induced by haplo-insufficiency of
Sox 9 [18].
In human normal articular chondrocytes, Sox 9 expres-
sion was progressively reduced by passage in monolayer
cell culture [41]. Moreover its expression is reduced in
osteoarthritic chondrocytes compared to the normal ar-
ticular chondrocytes [23] and has therefore been sugges-
ted to contribute in osteoarthritis disease processes by
altering the ECM gene expression [42]. Thus, improving
the expression of Sox 9 by 1, 25 (OH)2D3 treatment could
AB
Figure 1 The effect of 1, 25 (OH)2D3 on protein expression of Sox 9 in equine articular chondrocytes following 24 h of incubation. (A)
Western blot analysis of protein expression levels using an antibody raised against the Sox 9 protein. Freshly isolated equine whole chondrocyte
lysate was used as a positive control C. β-actin was used as an internal load control. (B) the level of expression of the protein following 24 h of
incubation with different doses (1 ? 10 −9 and 1 ? 10 −12) of 1, 25 (OH)2D3 treatment in addition to the solvent (DMSO). Values are presented as
means ? S.E. ***Indicates statistically significant at P < 0.001.
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ment of osteoarthritis.
In fetal cartilage as well as in mature cartilage, the main
role of Sox 9 is to maintain the chondrocyte phenotype
in addition to inhibition of hypertrophic chondrocyte
differentiation [43]. Therefore, down regulation of Sox
9 expression was suggested to be a precondition for
hypertrophic alteration occurring in degenerative cartilage
[42,44]. As Sox 9 protein is augmented by 1, 25 (OH)2D3
treatment, this study suggests that 1, 25 (OH)2D3 treat-
ment could be utilized to improve the ECM proteins
biosynthesis by enhancing the anabolic activities of ar-
ticular chondrocytes. After further passages, chondro-
cytes have been shown to exhibit a more pronounced
de-differentiated phenotype and lower levels of Sox 9
[41]. Further studies on the effects of 1, 25 (OH)2D3
upon these cells would be of great interest.
We have previously shown that the expresson of both
TRPV5 and 6 channels, at the protein level, are inversely
related to chondrocyte de-differentiation [24]. In this stu-
dy we therefore examined the influence of 1, 25 (OH)2D3
treatment on the expression of TRPV5/6 channels on pri-
mary equine articular chondrocytes isolated at passage
two. The findings of the current study indicated that nostatistically significant changes were observed on the ex-
pression of TRPV5 and TRPV6 channels at the protein
level following treatment with different doses of 1, 25
(OH)2D3 (Figure 2). To ensure that 1, 25 (OH)2D3 had no
effect on the expression of these channels we also exa-
mined its effect upon their transcript levels but again no
significant changes were observed (Figure 3). Previous stu-
dies conducted on mouse investigated the effect of 1, 25
(OH)2D3 on epithelial Ca
2+ transport including TRPV5
and 6 channels following 1, 25 (OH)2D3 treatment [45,46].
These studies demonstrated that the expression of TRPV5
and TRPV6 channels in kidney and duodenum were
stimulated by binding of VDR (vitamin D receptor) at
transcriptional level. TRPV6 was reported to have sev-
eral classes of VDREs (vitamin D response elements) in
humans and the mouse [45,47,48].
In the vitamin D receptor knockout mice model, the
level of gene expression pattern of the TRPV6 and 5
channels in duodenum is dramatically down-regulated,
in contrast no changes are observed in gene expression
of other Ca2+ transporters [49,50]. The role of vitamin D
in the stimulation of Ca2+ transporters has emerged re-
cently. Therefore, the correlation between 1, 25 (OH)2D3
treatment and Ca2+ transport proteins were investigated
AB
C D
Figure 2 Expression of TRPV5 and TRPV6 channels in equine articular chondrocytes at the protein level. The changes in expression of
TRPV5 (A) and TRPV6 (B) channels following treatment with 1, 25 vit D were assessed by densitometry analysis of western blots and normalized
to the expression of housekeeping protein (β-Tubulin). Equine kidney (K) lysate was used as a positive control.Levels of expression at the protein
level of the TRPV5 (C) and TRPV6 (D) channels following 24 h of incubation with different doses of 1, 25 (OH)2D3 in addition to the solvent
(DMSO). Data presented as a mean ? S.E.
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increase the expression of TRPV6 channel, calbinding-
D9k and PMCA1b genes in Caco-2 cell lines [36,51].
This finding was not consistent with the current study,
where no changes were observed on the expression of
either TRPV5 or 6 channels at mRNA level or protein
levels. As stated above we have previously observed an
inverse correlation between TRPV 5 and 6 levels and
differentiation state. The current study suggests that the
changes in levels may not be directly linked to the de-
differentiation process. This however, needs further study
as does the mechanism by which Sox-9 is regulated by 1,25 (OH)2D3. Ca
2+ ions and Ca2+ channels have been im-
plicated in chondrocyte metabolism [52,53]. In vitro studies
show that augmented extracellular Ca2+ promotes differen-
tiation toward a hypertrophic phenotype, in contrast Ca2+
reduction improves ECM protein synthesis including col-
lagen type II and aggrecan and delays hypertrophy [54].
Therefore, investigating the effect of the 1, 25 (OH)2D3 on
the expression of Ca2+ channels could be considered as a
candidate for treatment of joint diseases.
The results of the current study do not, however, sug-
gest an involvement of TRPV5/6 ion channels in the
regulation of vitamin D mediated up-regulation of sox-9.
AB
C D
Figure 3 Expression of TRPV5/6 at the mRNA level. End point PCR analysis of TRPV5 (A) and TRPV6 (B) ion channel genes on mRNA isolated
from equine articular chondrocytes. The graphs show real-time PCR analysis of TRPV5 (C) and TRPV6 (D) ion channel gene expression levels.
Experiments were carried out on equine articular chondrocytes (control) and treated with different doses of 1, 25 (OH)2D3. GAPDH and HPRT were
included as internal controls. Data presented as a mean ? S.E.
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This study examined the effects of the active form of
vitamin D (1, 25 (OH)2D3) upon the expression of tran-
scription factor Sox 9 and the calcium sensitive TRPV 5
and 6 channels, in equine articular chondrocytes, in vitro.
An increased expression of Sox 9, in these chondrocytes,
in response to the active form of vitamin D suggeststhat this compound acts to inhibit the progressive de-
differentiation that is normally observed in these cells.
It is also supportive of previous studies indicating that
1α, 25-dihydroxyvitamin D3 can have a protective effect
upon cartilage in animals in vivo. There was no effect
of vitamin D (1, 25 (OH)2D3) upon the expression of
either TRPV channel at either the protein or mRNA
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http://www.janimscitechnol.com/content/56/1/33level. We have previously observed a correlation bet-
ween the degree of differentiation and the expression
levels of TRPV 5/6 and suggested that these ion chan-
nels may have a direct interaction with the differenti-
ation process in vitro. The data in the present study do
not support this.
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